Jolynn Knoche Sessions, Pharm.D.

Associate Professor of Clinical Ed.

Jolynn Sessions, Pharm.D., is the clinical pharmacist faculty in oncology at Mission Health System  in Asheville, North Carolina. Sessions is an associate professor of clinical education at the UNC Eshelman School of Pharmacy’s Asheville satellite campus.

Previously at the Charles George VAMC in Asheville, Sessions was the first oncology clinical pharmacist provider in the oncology clinic and directed the anemia clinic from 2008 to 2014. She moved from Atlanta in 2008 where she was the oncology clinical coordinator, oncology PGY2 residency director and clinical pharmacist at Emory Hospital/Winship Cancer Institute in Atlanta from 1999 to 2008. Her first job out of specialty residency was at Grady Health System in Atlanta where she developed the role of an oncology clinical pharmacist and established both clinical and distributive services from 1997 to 1999. Precepting students and residents has been an integral and fulfilling honor in all of her clinical experiences.

Sessions is a graduate of the University of Florida College of Pharmacy. Through pharmacy school, she worked as an intern and technician at Moffitt Cancer Center in Tampa, Florida, and it was there that her passion for oncology pharmacy began, with the help of excellent mentors. She completed a PGY1 residency at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, and then a PGY2 residency at UT MD Anderson Cancer Center in Houston, Texas.

Sessions is a member of the Hematology Oncology Pharmacy Association and has served as treasurer, board of directors, chair and vice chair of continuing education committee. She is also a member of the North Carolina Oncology Pharmacists Association.

Adult oncology, direct patient care

Publications

2010

  • Sessions JK, Valgus J, Barbour SY, Iacovelli L.  Role of Oncology Clinical Pharmacists in Light of the Oncology Workforce Study. Journal of Oncology Practice 2010;6(5):270-272.

2009

  • Stricker S, Sessions J. Beyond Chemotherapy: Non-Hodgkin’s Lymphoma Update in The Oncology Nurse/The Oncology Pharmacist, May 2009 Vol.2, No 3, 23-27.

Poster Presentations

2013

  • Sessions J, Patterson D, Laughter D. Correct Level of Care: Optimizing Oncology Care at the Charles George VAMC. Poster presentation at AVAHO (Association of VA Hematology Oncology). September 2013.

2009

  • Sessions J, Peek B, Combs J.  Process for Comparing Oncology Practices.  Poster presentation at AVAHO (Association of VA Hematology Oncology) September 9, 2009

Invited Presentations

2014

  • CML Debate: Beyond first line therapy. At tenth annual HOPA (Hematology Oncology Pharmacy Association 2012 conference. March 26, 2014.  0465-0000-14-005-L01-P

2013

  • Oncology Pharmacy Bootcamp: GI Toxicities of Chemotherapy. Part of National VA virtual training series. July 23, 2013.

2012

  • Lung Cancer Update: screening and novel treatments.  Charles George VA Medical Center, December 5, 2012. Presented with oncologist James Puckett, MD. 1 hour of AMA PRA category 1 CME.
  • Nausea and Vomiting Control in Multi-day Chemotherapy in Clinical Pearls and Interesting Cases. At the annual North Carolina Oncology Pharmacist Meeting (NCOP). August 11, 2012. 0088-9999-12-050-L01-P
  • Prostate Cancer Update.  Charles George VA Medical Center. January 18, 2012.  Presented with oncologist James Puckett, MD. 1 hour of AMA PRA category 1 CME.
  • Controversies in Care: Hematology. Chronic Myelogenous Leukemia: Dasatinib Dosing & Monitoring at eighth annual HOPA (Hematology Oncology Pharmacy Association 2012 conference. March 22, 2012

2011

  • The Evolving Management of Chronic Myeloid Leukemia: Pharmacist Considerations.  Live Interactive webcasts on July 13th, 26th and August 3rd, 2011. 0064-0000-11-201-L01P

2010

  • New Drug Update.  At the annual North Carolina Oncology Pharmacist Meeting. August 14, 2010. 088-9999-10-056-L01P
  • Chronic Myelogenous Leukemia: Evolving Treatment Strategies. At sixth annual HOPA (Hematology Oncology Pharmacy Association 2010 conference.  March 25th 2010. 0465-0000-10-029-H01P

2009

  • New Drug Update.  At the annual North Carolina Oncology Pharmacist Meeting. August 15, 2009. 088-999-09-054-L01P
  • To “Nib” or to Cut? Hepatocellular Carcinoma Update – Board Certification Oncology Pharmacist Lecture 2009.  At the fifth annual HOPA (Hematology Oncology Pharmacy Association) 2009 Conference. June 18, 2009. 465-999-09-L01P
  • Clinical Pearls – Cutaneous side effects from EGFR inhibitors. North Carolina Association of Pharmacists Acute Care Practice Forum Spring Meeting.  March 25, 2009. 088-999-09-006-L04-P

Doctorate of Pharmacy from University of Florida College of Pharmacy 1995

7/96-7/97  ASHP-Accredited Specialty Residency in Oncology Pharmacy Practice, UT M.D. Anderson Cancer Center, Houston, Texas

7/95-6/96  ASHP-Accredited Pharmacy Practice Residency, North Carolina Baptist Hospitals, Inc., Bowman Gray/Baptist Hospital Medical Center, Winston-Salem, North Carolina